Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 18, Number 7—July 2012

Validity of International Health Regulations in Reporting Emerging Infectious Diseases

Michael EdelsteinComments to Author , David L. Heymann, Johan Giesecke, and Julius Weinberg

Author affiliations: London School of Hygiene and Tropical Medicine, London, UK (M. Edelstein, D.L. Heymann); Chatham House, London (D.L. Heymann); European Centre for Disease Control, Stockholm, Sweden (J. Giesecke); and Kingston University, London (J. Weinberg)

Main Article

Table 2

Characteristics of 175 EID events reported to WHO*

Characteristic No. (%)
Type of pathogen
Bacterium 89 (50.9)
Virus 39 (22.3)
Rickettsia 12 (6.9)
Protozoan 20 (11.4)
Helminth 2 (1.1)
Fungus 12 (6.9)
Prion 1 (0.6)
WHO region
AMRO 77 (44.0)
EURO 49 (28.0)
EMRO 7 (4.0)
SEARO 10 (5.7)
WPRO 24 (13.7)
AFRO 8 (4.6)
Type of event
New pathogen 70 (40.0)
Increased incidence 44 (25.1)
Antimicrobial drug resistance 54 (30.9)
New clinical manifestation 7 (4.0)

*EID, emerging infectious disease; WHO, World Health Organization; AMRO, Americas; EURO, Europe; EMRO, Eastern Mediterranean; SEARO, Southeast Asia; WPRO, Western Pacific; AFRO, Africa.

Main Article

Page created: May 30, 2012
Page updated: May 30, 2012
Page reviewed: May 30, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.